Cann Financial Statements From 2010 to 2025

CNGGF Stock  USD 0.01  0.0001  1.59%   
Cann Group's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Cann Group's valuation are provided below:
Cann Group Limited does not presently have any fundamental signals for analysis.
Check Cann Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cann Group's main balance sheet or income statement drivers, such as , as well as many indicators such as . Cann financial statements analysis is a perfect complement when working with Cann Group Valuation or Volatility modules.
  
This module can also supplement various Cann Group Technical models . Check out the analysis of Cann Group Correlation against competitors.

Cann Group Limited Company Operating Margin Analysis

Cann Group's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current Cann Group Operating Margin

    
  (2.16) %  
Most of Cann Group's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cann Group Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, Cann Group Limited has an Operating Margin of -2.1576%. This is 93.85% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The operating margin for all United States stocks is 60.84% lower than that of the firm.

Cann Group Limited Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Cann Group's current stock value. Our valuation model uses many indicators to compare Cann Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cann Group competition to find correlations between indicators driving Cann Group's intrinsic value. More Info.
Cann Group Limited is rated fifth in return on equity category among its peers. It also is rated fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cann Group's earnings, one of the primary drivers of an investment's value.

About Cann Group Financial Statements

Cann Group stakeholders use historical fundamental indicators, such as Cann Group's revenue or net income, to determine how well the company is positioned to perform in the future. Although Cann Group investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cann Group's assets and liabilities are reflected in the revenues and expenses on Cann Group's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cann Group Limited. Please read more on our technical analysis and fundamental analysis pages.
Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets. The company was founded in 2014 and is based in Port Melbourne, Australia. Cann operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.

Currently Active Assets on Macroaxis

Other Information on Investing in Cann Pink Sheet

Cann Group financial ratios help investors to determine whether Cann Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cann with respect to the benefits of owning Cann Group security.